Clearside Biomedical (CLSD) P/E Ratio
P/E Ratio as of Jun 13, 2025: -1.96
Average-1.98
Median-1.97
Minimum-2.18
Maximum-1.80
-1.96
Past Month+0.16 (7.55%)
The P/E ratio for Clearside Biomedical (CLSD) is -1.96 as of Jun 13, 2025. This represents a decrease of -9.26% compared to its 12-month average P/E ratio of -2.16. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Clearside Biomedical P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Clearside Biomedical’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Clearside Biomedical to industry peers.
Clearside Biomedical P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Clearside Biomedical’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Clearside Biomedical to industry peers.
Clearside Biomedical (CLSD) P/E Ratio Insights
See Clearside Biomedical’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Clearside Biomedical (CLSD)
Order type
Buy in
Order amount
Est. shares
0 shares
Clearside Biomedical (CLSD) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $0.7399 | -1.81 |
| May 1, 2025 | $0.8518 | -1.82 |
| Apr 1, 2025 | $0.9076 | -1.93 |
| Mar 3, 2025 | $0.7925 | -1.76 |
| Feb 3, 2025 | $0.94 | -2.09 |
| Jan 2, 2025 | $0.955 | -2.12 |
Clearside Biomedical (CLSD) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.96 | -7.11% |
| 2024 | -2.11 | +9.90% |
| 2023 | -1.92 | -86.05% |
| 2022 | -13.76 | -94.60% |
| 2021 | -254.63 | +3,516.90% |
| 2020 | -7.04 | — |
FAQs About Clearside Biomedical (CLSD) P/E ratio
The latest P/E ratio of Clearside Biomedical (CLSD) is -1.96, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Clearside Biomedical’s last 12-month average P/E ratio is -2.16, compared to its current P/E ratio of -1.96. This reflects a decrease of -9.26%.
Clearside Biomedical’s current P/E ratio of -1.96 is lower than its last 12-month average P/E of -2.16. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Clearside Biomedical’s average P/E ratio over the last 3 years is -6.57. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Clearside Biomedical’s average P/E ratio over the last 5 years is -25.76. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.